Enanta Pharmaceuticals (ENTA)
(Real Time Quote from BATS)
$12.87 USD
+0.22 (1.74%)
Updated May 13, 2024 04:00 PM ET
After-Market: $12.92 +0.05 (0.39%) 4:16 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -1.49 |
EPS Last Quarter | -1.47 |
Last EPS Surprise | -16.67% |
ABR | 2.71 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.86 |
Next Year | -4.80 |
EPS (TTM) | -6.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 17.30M | 17.70M | 70.16M | 76.58M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 19.70M | 20.00M | 73.60M | 111.94M |
Low Estimate | 15.12M | 15.82M | 67.55M | 62.85M |
Year ago Sales | 18.89M | 18.93M | 79.20M | 70.16M |
Year over Year Growth Est. | -8.43% | -6.49% | -11.42% | 9.15% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.49 | -1.46 | -5.86 | -4.80 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -1.48 | -1.49 | -6.02 | -5.82 |
High Estimate | -1.28 | -1.17 | -5.45 | -4.07 |
Low Estimate | -1.73 | -1.78 | -6.30 | -5.82 |
Year ago EPS | -1.86 | -1.33 | -6.38 | -5.86 |
Year over Year Growth Est. | 19.89% | -9.77% | 8.15% | 17.99% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 2 |
Up Last 30 Days | 0 | 0 | 0 | 2 |
Up Last 60 Days | 0 | 0 | 0 | 2 |
Down Last 7 Days | 5 | 5 | 5 | 3 |
Down Last 30 Days | 5 | 5 | 5 | 3 |
Down Last 60 Days | 5 | 5 | 5 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -1.49 | -1.46 | -5.86 | -4.80 |
7 Days Ago | -1.20 | -0.99 | -4.90 | -4.55 |
30 Days Ago | -1.20 | -0.99 | -4.90 | -4.55 |
60 Days Ago | -1.20 | -0.99 | -4.90 | -4.55 |
90 Days Ago | -1.20 | -0.99 | -4.90 | -4.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.49 | -1.46 | -5.86 | -4.80 |
Zacks Consensus Estimate | -1.49 | -1.46 | -5.86 | -4.80 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.47 | -1.58 | -1.33 | -1.86 | NA |
Estimate | -1.26 | -1.18 | -2.11 | -2.38 | NA |
Difference | -0.21 | -0.40 | 0.78 | 0.52 | 0.17 |
Surprise | -16.67% | -33.90% | 36.97% | 21.85% | 2.06% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more